Verified Sponsor Execution & Regulatory Ledger
| Sponsor Metric | Verified Count / Rate |
|---|---|
| Phase II & III Protocols (2018 to 2026) | 29 |
| Active Pipeline (Recruiting Now) | 11 (6) |
| Completed vs Stopped Early | 9 / 3 (10.3%) |
| Median Closed Actual Enrollment | 21 participants |
| Physical Hospital Site Disclosure | 100.0% named hospitals |
| FDA Drugs@FDA Original NDA/BLA Approvals | 0 (0 since 2018) |
Top Partner U.S. Hospital Clinical Research Sites
| Hospital Research Site | Location | Shared Protocols |
|---|---|---|
| Oregon Health and Science University Knight Cancer Institute | Portland, OR | 22 |
Related Filings Across Meru Platforms
Verified cross-ledger federal filings for Oregon Health & Science University (OHSU) across sibling Meru public-data platforms.
Explore interactive annual charts and M&A subsidiary rollups in the Oregon Health and Science University Interactive Dossier, benchmark peers in Rare Genetic, Women's Health, and Other, or review the Healthcare Price & Patent Cliff Crosswalk.